Functioning PanNETs in patients with MEN1 include insulinomas (10%), rarely gastrinomas, glucagonomas (<1%), somatostatinomas (1%), and vasoactive intestinal peptide-secreting tumors (VIPomas) (<1%) [9]. Here, MEN1 is linked to gastrin-producing neuroendocrine tumor.